Search Results - "Vorovitch, M. F."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin by Chernokhaeva, L.L, Rogova, Yu.V, Vorovitch, M.F, Romanova, L.Iu, Kozlovskaya, L.I, Maikova, G.B, Kholodilov, I.S, Karganova, G.G

    Published in Vaccine (29-04-2016)
    “…Highlights • Several factors do not affect the assessment of TBE vaccine protective efficacy in vivo. • TBE vaccine Moscow induces immune response in…”
    Get full text
    Journal Article
  2. 2

    Immunogenicity and safety of the adult tbe vaccine «tick-e-vac by Vorovitch, M. F., Maikova, G. B., Chernokhaeva, L. L., Romanenko, V. V., Ankudinova, A. V., Khapchaev, Yu. Kh, Karganova, G. G., Ishmukhametov, A. A., Drozdov, S. G.

    Published in Voprosy virusologiĭ (20-04-2017)
    “…About 3,000 cases of TBE are registered annually in the Russian Federation. Vaccination is the main way to prevent the tick-borne encephalitis disease…”
    Get full text
    Journal Article
  3. 3

    Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain by Vorovitch, M. F., Kozlovskaya, L. I., Romanova, L. Iu, Chernokhaeva, L. L., Ishmukhametov, A. A., Karganova, G. G.

    Published in SpringerPlus (09-12-2015)
    “…Vaccines based on the strain Sofjin of the Far-Eastern tick-borne encephalitis virus (TBEV) subtype have been used for TBE prophylaxis for over 50 years in…”
    Get full text
    Journal Article
  4. 4

    Vaccines based on the Far-Eastern and European strains induce the neutralizing antibodies against all known tick-borne encephalitis virus subtypes by Maikova, G. B., Chernokhaeva, L. L., Vorovitch, M. F., Rogova, Yu. V., Karganova, G. G.

    Published in Voprosy virusologiĭ (28-06-2016)
    “…Serum of children aged 1 to 16 obtained in the course of clinical trials conducted in the sverdlovsk region in 2011 was used to study the post-vaccination…”
    Get full text
    Journal Article
  5. 5

    Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3) by Khapchaev, Yu. H., Ivanova, O. E., Vorovitch, M. F., Romanenko, V. V., Makarov, A. E., Drozdov, S. G., Ishmukhametov, A. A.

    “…Through the use of trivalent oral poliovirus vaccine made from Sabin strains of types 1, 2, 3 (tOPV), outstanding success of Global polio eradication program…”
    Get full text
    Journal Article
  6. 6

    Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice by Khoretonenko, M.V, Vorovitch, M.F, Zakharova, L.G, Pashvykina, G.V, Ovsyannikova, N.V, Stephenson, J.R, Timofeev, A.V, Altstein, A.D, Shneider, A.M

    Published in Immunology letters (15-12-2003)
    “…A vaccinia virus recombinant containing the non-structural tick-borne encephalitis virus (TBEV) NS1 gene was developed. The recombinant expressed native…”
    Get full text
    Journal Article
  7. 7

    monoclonal antibody that recognizes the predicted tick-borne encephalitis virus E protein fusion sequence blocks fusion by Volkova, T. D, Vorovitch, M. F, Ivanov, V. T, Timofeev, A. V, Volpina, O. M

    Published in Archives of virology (01-01-1999)
    “…The fusion motif of tick-borne encephalitis virus E protein has been predicted to be located within its conserved region (98–120). Results are presented to…”
    Get full text
    Journal Article
  8. 8

    A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model by Volpina, O.M., Volkova, T.D., Koroev, D.O., Ivanov, V.T., Ozherelkov, S.V., Khoretonenko, M.V., Vorovitch, M.F., Stephenson, J.R., Timofeev, A.V.

    Published in Virus research (01-09-2005)
    “…Linear immunogenic peptides corresponding to amino acid sequences from the NS1 non-structural protein from tick-borne encephalitis virus (strain Sophyin) were…”
    Get full text
    Journal Article
  9. 9

    pH-dependent fusion of tick-borne encephalitis virus with artificial membranes by VOROVITCH, M. F, TIMOFEEV, A. V, ATANADZE, S. N, TUGIZOV, S. M, KUSHCH, A. A, ELBERT, L. B

    Published in Archives of virology (01-01-1991)
    “…pH-dependent fusion of TBE virus with artificial membranes was effective at slightly acidic pH with maximum at 6.4. The influence of various changes in E…”
    Get full text
    Journal Article
  10. 10

    Perspectives for applying Alphaviruses in antitumor therapy by Nazarenko, Alina S., Biryukova, Yulia K., Kolyasnikova, Nadezhda M, Vorovich, Mikhail F., Pestov, Nikolai B., Ishmukhametov, Aidar A.

    Published in Infekt͡s︡ii͡a︡ i immunitet (24-10-2023)
    “…Oncolytic viral therapy is a promising approach for treating tumors. Oncolytic viruses can directly lyse tumor cells and indirectly activate antitumor…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines by Nazarenko, A S, Biryukova, Y K, Orlova, E O, Trachuk, K N, Ivanova, A L, Belyakova, A V, Pestov, N B, Vorovitch, M F, Ishmukhametov, A A, Kolyasnikova, N M

    Published in Voprosy virusologii (26-12-2023)
    “…Flaviviruses, possessing natural neurotropicity could be used in glioblastoma therapy using attenuated strains or as a delivery system for antitumor agents in…”
    Get more information
    Journal Article